COBBLL1 GENE AS A PREDICTIVE FACTOR OF RESPONSE IN NEWLY DIAGNOSED FIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH NON-MUTANT TP53 AND MUTANT IGHV

EHA Library, Maher Salamoon, 421298

MOLECULAR STABILITY AND KINETICS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA DURING IBRUTINIB TREATMENT

EHA Library, Sólja Remisdóttir Veyhe, 421300

THE IMPORTANCE OF PCR ANALYSIS OF IGH AND TCR-Γ GENE REARRANGEMENTS ON RICHTER TRANSFORMATION.

EHA Library, CARMEN HERERO CARRASCO, 421302

CELESTIAL-TNCLL: AN ONGOING, OPEN-LABEL, MULTIREGIONAL, PHASE 3 STUDY OF SONROTOCLAX (BGB-11417) + ZANUBRUTINIB VS VENETOCLAX + OBINUTUZUMAB FOR TREATMENT-NAIVE (TN) CLL

EHA Library, Piers Patten, 421304

A PHASE 2 STUDY EVALUATING DOSE MODIFICATION APPROACHES FOR IBRUTINIB MONOTHERAPY OR IBRUTINIB+VENETOCLAX COMBINATION IN PATIENTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: TAILOR

EHA Library, Paolo Ghia, 421307

REPEATED COVID-19 EVENTS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Sara Pepe, 421309

TRIAL IN PROGRESS: PROSPECTIVE STUDY OF FIXED-DURATION IBRUTINIB+VENETOCLAX (IBR+VEN) FOR FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN A REAL-WORLD SETTING: THE REALITY STUDY

EHA Library, Paolo Ghia, 421311

RECENT PATTERNS OF CARE WITH BTK INHIBITORS AND DISTRIBUTION OF SOCIAL DETERMINANTS OF HEALTH AMONG PATIENTS WITH CLL/SLL IN THE US COMMUNITY SETTING

EHA Library, David J. Andorsky, 421312

TREATMENT RESULTS WITH FLUDARABINE CYCLOPHOSPHAMIDE AND RITUXIMAB AS FIRST LINE THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS IN ALBANIA

EHA Library, Rozita Çaka, 421313

THE IMPACT OF HIGH AND LOW BURDEN TP53 MUTATION ON RISK AND TREATMENT DECISION IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Maher Salamoon, 421314

CORRELATION BETWEEN PROGRESSION FREE SURVIVAL AND OVERALL SURVIVAL AMONG PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA: A CLINICAL TRIAL-BASED APPROACH

EHA Library, Vikalp Maheshwari, 421315

REAL WORLD INCIDENCE OF TOXICITY FROM VENETOCLAX IN CLL

EHA Library, Sabrina Habib, 421316

SARS-COV-2 AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CLINICAL AND IMMUNOLOGICAL OBSERVATIONS OF A REGIONAL CLINICAL REGISTER BETWEEN 2020 AND 2023

EHA Library, Dietrich KÄMPFE, 421317

HAIRY CELL LEUKEMIA: RETROSPECTIVE AND DESCRIPTIVE STUDY OF 7 PATIENTS

EHA Library, Nourhene Guedri, 421318

LONG TERM EFFICACY AND SAFETY OF IBRUTINIB: A SINGLE CENTER EXPERIENCE

EHA Library, Svilena Atanasova, 421319

ASSOCIATION OF TP53 MUTATION WITH BINET STAGE, ABSOLUTE LYMPHOCYTE COUNT AND  LYMPHOCYTE DOUBLING TIME IN B CELL CHRONIC LYMPHOCYTIC LEUKEMIA: A TERTIARY CARE CENTER EXPERIENCE FROM PAKISTAN.

EHA Library, Syeda Mah Ali, 421320

IBRUTINIB FOR CHRONIC LYMPHOCYTIC LEUKEMIA IN A CHINESE REAL-WORLD SETTING

EHA Library, Shenmiao Yang, 421321

CHARACTERIZATION AND OUTCOMES OF THE SPANISH PATIENTS INCLUDED IN THE GLOW AND CAPTIVATE-FD STUDIES: IBRUTINIB PLUS VENETOCLAX FOR FIRST-LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).

EHA Library, JOSE ANGEL HERNANDEZ RIVAS, 421322

REAL-WORLD ANALYSIS OF PATIENTS WITH CLL TREATED WITH IBRUTINIB: A RETROSPECTIVE ANALYSIS OF THE BRAZILIAN REGISTRY OF CLL

EHA Library, Verena Pfister, 421323

REAL-WORLD DISEASE CHARACTERISTICS AND FIRST-LINE THERAPY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN BULGARIA: THE DESCRIBE STUDY (INTERIM ANALYSIS)

EHA Library, Vanya Slavcheva, 421324

REAL-LIFE OF PATIENTS (PTS) WITH CHRONIC LYMPHATIC LEUKEMIA (CLL) AND SMALL LYMPHOCYTIC LYMPHOMA (SCLL) WITH BRUTON TYROSIN KINASE INHIBITORS (BTKI)

EHA Library, María Irene Nuevo López, 421325

AUSTRALASIAN BURTON TYROSINE KINASE INHIBITOR CARDIOVASCULAR TOXICITY CONSENSUS STATEMENT

EHA Library, Leanne Berkahn, 421326

REAL-WORLD UTILISATION OF BRUTON TYROSINE KINASE INHIBITORS IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA IN AUSTRALIA

EHA Library, Stephen Mulligan, 421327

REAL-WORLD ANALYSIS OF ORELABRUTINIB IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)

EHA Library, Wenjuan Yu, 421328

RICHTER'S TRANSFORMATION OF CHRONIC LYMPHOCYTIC LEUKEMIA. CASES REPORT AND REVIEW OF THE LITERATURE

EHA Library, Soraya Bougherira, 421329

IMPACT PRONOSTIQUE DU RAPPORT PLAQUETTES/LYMPHOCYTES (PLR) DANS LA LEUCÉMIE LYMPHOÏDE CHRONIQUE AU SERVICE D'HÉMATOLOGIE CLINIQUE DE MONASTIR/TUNISIE

EHA Library, ons charef, 421330

CONSENSUS-BASED BEST PRACTICE RECOMMENDATIONS FOR CLL MANAGEMENT IN ROUTINE CLINICAL PRACTICE IN CAMPANIA: SYSTEMATIC LITERATURE REVIEW AND CLINICAL PRACTICE RECOMMENDATIONS FROM LOCAL CONSENSUS GROUP

EHA Library, Claudia Giordano, 421331

RETROSPECTIVE STUDY TO DESCRIBE REAL-WORLD TREATMENT PATTERNS AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL) FROM THE C3I LYMPHOMA REGISTRY IN QUEBEC

EHA Library, Isabelle Fleury, 421332

IMPLEMENTATION AND EARLY OUTCOMES OF A TREATMENT ACCESS PROGRAM FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN NEPAL AND ARMENIA

EHA Library, Andrielle Yost, 421333

OBINUTUZUMAB AS DEBULKING THERAPY FOR A SUCCESSFUL DELIVERED OF FIXED-DURATION VENETOCLAX–OBINUTUZUMAB TREATMENT IN AN ELDERLY CLL PATIENT WITH EXTREMELY HIGH WHITE BLOOD COUNT – A CASE REPORT

EHA Library, Dario Leotta, 421334

NEUROMENINGEAL TRANSFORMATION IN CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICAL INSIGHTS FROM A CASE REPORT

EHA Library, Kmar Mrad, 421335

GLYCATED ALBUMIN PREDICTS INFERIOR PROGNOSIS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Xin Wang, 421336

THE EFFECTS OF AN ONLINE CURRICULUM BASED APPROACH TO CME ON HEMATOLOGIST/ONCOLOGISTS’ ABILITY TO TREAT PATIENTS WITH BTK INHIBITORS FOR CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA

EHA Library, Victoria Harvey-Jones, 421337

EPIDEMIOLOGY OF CHRONIC LYMPHOCYTIC LEUKEMIA IN A HEALTH´S AREA OF SOUTH SPAIN.

EHA Library, Jose Ramon Garcia Fernandez, 421338

CLADRIBINE TREATMENT IN HAIRY CELL LEUKEMIA: ALGERIAN MONOCENTRIC RETROSPECTIVE STUDY

EHA Library, Rihab Benouattas, 421339

ACALABRUTINIB MONOTHERAPY FOR TREATMENT NAIVE AND RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: SINGLE CENTER REAL WORLD DATA ON EFFICACY AND SAFETY

EHA Library, Maria Dimou, 421340

THE CLINICAL AND HEMATOPATHOLOGY ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA ACCOMPANIED WITH T(18;22)(Q21;Q11) CHROMOSOME TRANSLOCATION AND LITERATURE REVIEW

EHA Library, Shaobin Yang, 421341

RISK OF SECOND PRIMARY MALIGNANCIES IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Soraya Bougherira, 421342

ENHANCING EFFICIENCY AND COST-EFFECTIVENESS IN SUBCUTANEOUS IMMUNOGLOBULIN REPLACEMENT THERAPY HOME TRAINING: INSIGHTS FROM A STUDY ON INFUSION PUMP CHOICES AND TRAINING PROTOCOLS

EHA Library, Brent Rutland, 421343

PROMOTING TREATMENT ADHERENCE IN SECONDARY IMMUNE DEFICIENCIES: EVALUATING THE ROLE OF SCIG PUMP SELECTION IN IMPROVING PATIENT OUTCOMES

EHA Library, Brent Rutland, 421344

IMMUNOLOGICAL BIOMARKERS TO DETERMINE THE TREATMENT SUCCESS ON CML PATIENTS ON DASATINIB

EHA Library, Hyojeong Ha, 421345

HIGH ACCURACY AND SENSITIVITY DIGITAL REAL-TIME PCR (DRPCR) PLATFORM FOR QUANTITATIVE DETECTION OF BCR::ABL1 TRANSCRIPTS DURING CHRONIC MYELOID LEUKEMIA TREATMENT

EHA Library, Hyun-Woo Song, 421346

PERFORMANCE COMPARISON EVALUATION OF ‘1COPY™ PROBE TECHNOLOGY-BASED 1COPY™ BCR::ABL1 QPCR KIT’ FOR QUANTITATIVE DETECTION OF BCR::ABL1

EHA Library, Jeakyung Bok, 421347

PROGRESSIVE DOWNREGULATION OF PROLIFERATION/SURVIVAL PATHWAYS OF CD34+/LIN- CELLS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AT DIAGNOSIS VS. 12 MONTHS OF NILOTINIB TREATMENT VS. HEALTHY SUBJECTS

EHA Library, Alessandra Trojani, 421348

MUTATIONS IN SIGNALING PATHWAYS IN ASSESSING THE PROGNOSIS OF THE DEVELOPMENT OF BCR::ABL-INDEPENDENT RESISTANCE TO TKIS

EHA Library, Daria Kustova, 421349

THE ESTABLISHMENT OF AN EX VIVO DRUG SENSITIVITY SCREENING AND DRUG REPURPOSING PLATFORM USING SOUTH AFRICAN LEUKAEMIA PATIENT SAMPLES

EHA Library, Mutsa Takundwa, 421350

MULTIPLE CYTOKINE PROFILING IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Tuiara Aleksandrova, 421351

MOLECULAR INTERROGATION OF CHRONIC MYELOID LEUKAEMIA PATIENTS WHO FAILED SECOND GENERATION TYROSINE KINASE INHIBITOR USING NEXT GENERATION SEQUENCING

EHA Library, Siew Lian Chong, 421352

CHARACTERISTICS OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE TREATED WITH ASCIMINIB AFTER ONE PRIOR TYROSINE KINASE INHIBITOR: A REAL-WORLD CHART REVIEW STUDY IN THE US

EHA Library, Ehab Atallah, 421353

PREVALENCE OF ARTERIAL HYPERTENSION AMONG PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA ON PONATINIB THERAPY

EHA Library, Elza Lomaia, 421354

A 10 YEAR OVERALL SURVIVAL ANALYSIS OF CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS IN A MAJOR HAEMATOLOGY CENTRE IN MALAYSIA : A REAL WORLD ANALYSIS

EHA Library, ZAKIAH BAKAR ALI, 421355

PROGNOSTIC MARKERS AND TREATMENT RESPONSE ASSESSMENT IN CHRONIC MYELOID LEUKEMIA: INSIGHTS FROM A RETROSPECTIVE STUDY IN TUNISIA

EHA Library, Sana Lakhel, 421356

A THREE-YEAR FOLLOW UP : REAL-WORLD STUDY OF ENDING TYROSINE KINASE INHIBITOR IN CHRONIC MYELOID LEUKAEMIA (ENTIC) IN MALAYSIA

EHA Library, Siew Lian Chong, 421357

REAL WORLD OUTCOMES FOR PATIENTS WITH CML DIAGNOSED AND TREATED AT A SINGLE INSTITUTION

EHA Library, Emily Rhinehart, 421358

DASATINIB INDUCED LYMPHOCYTOSIS IN CHRONIC MYELOID LEUKEMIA PATIENTS- REVIEW OF 46 CASES.

EHA Library, Priyavadhana Balasubramanian, 421359

DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF CHRONIC MYELOID LEUKEMIA PATIENTS OF ARMENIA: THE PREDICTIVE VALUES OF THE ELTS AND EUTOS SCORES:

EHA Library, Hasmik Maghakyan, 421360

CHRONIC MYELOID LEUKEMIA SURVEY ON UNMET NEEDS (CML SUN): UNITED KINGDOM FINDINGS ON BALANCING TOLERABILITY AND EFFICACY GOALS OF PATIENTS AND PHYSICIANS THROUGH SHARED TREATMENT DECISION-MAKING

EHA Library, Andrew McGregor, 421361

EVALUATION OF POST-COVID-19 CARDIOVASCULAR EVENTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Katia Pagnano, 421363

PROGNOSTIC SIGNIFICANCE OF BIOMARKERS OF MYOCARDIAL DAMAGE (MD) IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) DURING THERAPY WITH INHIBITORS TYROSINE KINASES (TKIS)

EHA Library, Nadezhda Shnalieva, 421364

COMEDICATION OF PROTON PUMP INHIBITORS WITH CRYSTALLINE DASATINIB IN CHRONIC MYELOID LEUKEMIA: COMMONLY OCCURRING AND CAUSING MARKEDLY REDUCED TKI-BIOAVAILABILITY

EHA Library, Torsten Dahlen, 421365

TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKAEMIA: A SINGLE-CENTRE EXPERIENCE IN THE UNITED KINGDOM

EHA Library, Adrian Choy, 421366

INTERACTION BETWEEN GUT MICROBIOME AND TYROSINE KINASE INHIBITORS IN DEFINING THE CLINICAL OUTCOMES OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Carmen Fava, 421367

ALLELE-SPECIFIC PCR FOR THE MAIN BCR::ABL KINASE DOMAIN MUTATIONS CONFERING RESISTANCE TO TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Anastasia Kartashova, 421368

SECOND TYROSINE KINASE INHIBITORS DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA-CHRONIC PHASE PATIENTS: SINGLE CENTER REAL-LIFE EXPERIENCE

EHA Library, Mariella D' Adda, 421369

ASSESSING THE TREATMENT RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS AFTER NEW COMBINATION TREATMENT

EHA Library, Basma Atef, 421370

CARDINAL: A PHASE I, MULTICENTER, OPEN-LABEL, DOSE-ESCALATION AND DOSE-OPTIMIZATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF TERN-701 IN CHRONIC MYELOID LEUKEMIA

EHA Library, Elias Jabbour, 421371

PROGNOSTIC RESTRATIFICATION OF A COHORT OF 72 PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROMES (MDS) USING THE MOLECULAR INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS-M).

EHA Library, Blanca Vegas, 421372

PANOBINOSTAT AND PIM-2 INHIBITORS PROMOTE THE APOPTOSIS OF MDS/AML MALIGNANT CELLS BY INHIBITING THE NF-ΚB PATHWAY

EHA Library, Zhaoyun Liu, 421373

THE POTENTIAL ROLE OF UBE2O IN THE TREATMENT OF INEFFECTIVE ERYTHROPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Beatrice Maffeo, 421374

TARGETING XPO1 AND PRL-3 INDUCED MITOCHONDRIAL DAMAGE AND APOPTOSIS IN MDS THERAPY

EHA Library, Zhaoyun Liu, 421375

THE EFFECTIVENESS OF COMBINING GLUTAMINASE INHIBITORS WITH THE DIABETIC MEDICATION METFORMIN IN TREATING MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA

EHA Library, Seiichi Okabe, 421376

EFFECT OF EPIGENETIC CHANGES IN PROGNOSIS OF YOUNG INDIAN PATIENTS WITH MYELODYSPLASTIC SYNDROMES : INDIAN STUDY

EHA Library, Rekha Chaubey, 421377

EPIGENETIC LANDSCAPE OF MDS EVOLUTION WITH 1Q JUMPING TRANSLOCATIONS AFTER 5’-AZACYTIDINE

EHA Library, Anair Graciela Lema Fernandez, 421378

FTH1 REPRESSES FERRITINOPHAGY-MEDIATED FERROPTOSIS IN THE ANEMIC PATHOGENESIS OF MYELODYSPLASTIC SYNDROMES

EHA Library, Liyan Yang, 421379

RESTORATION OF WNT INHIBITOR DICKKOPF-1 LEVELS NORMALIZES BONE MINERALIZATION BUT NOT ERYTHROPOIESIS IN MYELODYSPLASTIC MICE

EHA Library, Heike Weidner, 421380

BONE MARROW MESENCHYMAL STROMAL CELLS MODULATION IN MYELODYSPLASTIC SYNDROMES.

EHA Library, Matilde Boada, 421381

PROGNOSTIC IMPACT OF DONOR MITOCHONDRIAL GENOMIC VARIANTS IN MYELODYSPLASTIC NEOPLASMS AFTER STEM-CELL TRANSPLANTATION

EHA Library, Jing Dong, 421382

INCREASING ANTI-APOPTOTIC AND DECREASING PROLIFERATIVE ACTIVITY IN THE CD34-POSITIVE BLAST CELL POPULATION OF MDS AND AML AS COMPARED TO NON-MALIGNANT BONE MARROW

EHA Library, Mathie Leers, 421383

THE MESENCHYMAL STROMAL CELLS: A HUB FOR NATURAL KILLER CELL IMMUNE DYSREGULATION  IN MDS CONTEXT

EHA Library, Valeria Bisio, 421384

DEVELOPMENT OF APTAMERS AS THERAPY FOR CONGENITAL NEUTROPENIA DISEASES

EHA Library, Francisca Alcaraz-Pérez, 421385

VARIABILITY IN INTERPRETATION OF ARRAY RESULTS IMPACTING ON CORRECT PROGNOSTICATION OF MANY HAEMATOLOGICAL MALIGNANCIES – THROUGH AN EQA LENS

EHA Library, Fiona Oswald, 421386

GERMLINE DDX41 MUTATION IN SIBLING DONOR AND TRANSPLANT RECIPIENT, WITH IDENTICAL SECOND HIT DDX41 APPEARING YEARS LATER CAUSING DONOR DERIVED MYELODYSPLASTIC SYNDROME

EHA Library, Liselotte Vesterlund, 421387

THE MAXILUS STUDY: A TRIAL IN PROGRESS FOR LUSPATERCEPT AT MAXIMUM APPROVED DOSE IN PATIENTS WITH TRANSFUSION-DEPENDENT LOWER-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Matteo Giovanni Della Porta, 421388

CLINICAL IMPACT OF ASXL1 MUTATIONS IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS (HR-MDS) TREATED WITH HYPOMETHYLATING AGENTS: MULTICENTER RETROSPECTIVE ANALYSIS FROM THE VALIDATE DATABASE

EHA Library, Aram Bidikian, 421389

PLATELET FUNCTION PARAMETERS IN RELATION TO SOMATIC MYELOID MUTATIONS AND OUTCOME IN CHRONIC MYELOMONOCYTIC LEUKEMIA

EHA Library, Ebba Westerberg, 421390

THE EFFICACY OF LUSPATERCEPT IN TREATING REFRACTORY ANEMIA MIGHT NOT BE AFFECTED BY IPSS-R OR IPSS-M RISK

EHA Library, Guangsheng He, 421391

CYTOGENETIC ANNOTATION AUTOMATION IN MYELODYSPLASTIC SYNDROME RESEARCH DATABASES

EHA Library, Samuel Urrutia, 421392

TRIAL IN PROGRESS: PHASE II STUDY OF THE NLRP3 INFLAMMASOME & MYDDOSOME INHIBITOR HT-6184 IN PATIENTS WITH LOW OR INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, David J. Bearss, 421393

SOME RISK FACTORS FOR THE PROGRESSION OF MYELODYSPLASTIC SYNDROME TO ACUTE MYELOID LEUKEMIA

EHA Library, Halyna Starodub, 421394

MANAGEMENT OF PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) IN A LARGE US COMMUNITY ONCOLOGY PRACTICE: A FOCUS ON PATIENT OUTCOMES POST ERYTHROPOIETIN STIMULATING AGENT (ESA) TREATMENT

EHA Library, Gustavo Fonseca, 421395

REAL-WORLD CHARACTERISTICS AND TREATMENT PATTERNS AMONG PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES IN JAPAN

EHA Library, Takahiro Suzuki, 421396

GERMLINE UBA1 VARIANT WITH SOMATIC AMPLIFICATION IN A WOMAN WITH REFRACTORY INFLAMMATORY DISEASES AND MYELODYSPLASTIC SYNDROME

EHA Library, Maria Creignou, 421397

REAL-WORLD OUTCOMES OF HYPOMETHYLATING AGENTS FOR HIGHER-RISK MYELODYSPLASTIC SYNDROMES: REPORT FROM THE NATIONWIDE MULTI-CENTER THAI MDS STUDY GROUP

EHA Library, Theerin Lanamtieng, 421398

SALVAGE VENETOCLAX+AZACITIDINE THERAPY FOR SECONDARY AML IN AZACITIDINE FAILED PATIENTS. SINGLE CENTER EXPERIENCE.

EHA Library, Lubomir Minarik, 421399

SLEEP DISTURBANCES IN PATIENTS WITH MYELODYSPLASTIC NEOPLASIAS

EHA Library, Ekaterina Balaian, 421400

MYELOID NEOPLASMS WITH GERMLINE PREDISPOSITION - DDX41 MUTATION

EHA Library, Mafalda Urbano, 421401

REAL WORLD EFFICACY OF LUSPATERCEPT IN PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES/NEOPLASMS (MDS); A SINGLE CENTER STUDY IN A HEAVILY PRETREATED COHORT

EHA Library, Yazan Madanat, 421402

REAL WORLD OUTCOMES OF DECITABINE/CEDAZURIDINE AND AZACITIDINE FOR TREATMENT OF MDS/CMML: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Brittany Salter, 421403

THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A SINGLE CENTER ANALYSIS.

EHA Library, Nicole Galli, 421404

MANAGEMENT OF ANEMIA IN LOW-RISK MYELODYSPLASTIC SYNDROME PATIENTS IN LOW-RESOURCE SETTINGS: CONSIDERATIONS FOR IMMUNOSUPPRESSION OR ANDROGENS

EHA Library, Sebastian Burgos, 421405